VIDEO | Dr James Campbell on Proactive

Media, Video

Patrys CEO and MD, Dr James Campbell, was interviewed by Proactive’s Andrew Scott today to discuss the importance of the Company’s news that it has now developed and optimised a stable cell line for production of our full-sized IgG deoxymab, PAT-DX3.

Check out the interview here: